(1 - 18 from 22
)
Innate Pharma S.A. (IPHYF) CEO Mondher Mahjoubi on Q
article.wn.com
Innate Pharma S.A. (OTCPK:IPHYF) Q Results Earnings Conference Call March 20, :00 AM ET Company Participants Danielle Spangler - Investor ...
AZ swells immuno-oncology pipeline with Innate deal - PMLiVEwww.pmlive.com › pharma_news › az_swells_immuno-oncology_pipeline...
www.pmlive.com
Innate is run by former AZ executive Mondher Mahjoubi, who made the move to the CEO role at the French biotech last year, and as part of the ...
Innate Pharma S.A. Rings the Closing Bell in Celebration of its ...
www.nasdaq.com
... visited the Nasdaq MarketSite in Times Square. In honor of the occasion, Mondher Mahjoubi, MD, Chairman & CEO, rang the Closing Bell.
Innate, Bristol-Myers' plans stumble with trial miss | BioPharma Dive
www.biopharmadive.com
... understand the results and explore whether other combinations should be investigated," said Mondher Mahjoubi, CEO at Innate Pharma.
sorted by relevance / date